Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 252

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 252
---
   |     124,402 |   |     |   |           116,323 |   |
| Debentures                                                                                                                                                             |   |   4,700,000 |   |     |   |                 - |   |
| Total current liabilities                                                                                                                                              |   |   8,544,165 |   |     |   |         2,306,229 |   |
| Operating lease liability, non-current                                                                                                                                 |   |     141,753 |   |     |   |           205,945 |   |
| Total liabilities                                                                                                                                                      |   |   8,685,918 |   |     |   |         2,512,174 |   |
| Commitments and contingencies (Note 10)                                                                                                                                |   |             |   |     |   |                   |   |
| Shareholders' equity                                                                                                                                                   |   |             |   |     |   |                   |   |
| Common shares, no par value; unlimited shares authorized; 15,936,266 and 11,816,721 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively |   |  37,833,999 |   |     |   |        30,518,195 |   |
| Additional paid-in capital                                                                                                                                             |   |   5,597,106 |   |     |   |         1,520,412 |   |
| Accumulated deficit                                                                                                                                                    |   | (40,182,395 | ) |     |   |       (28,903,903 | ) |
| Total shareholders' equity                                                                                                                                             |   |   3,248,710 |   |     |   |         3,134,704 |   |
| Total liabilities and shareholders' equity                                                                                                                             | $ |  11,934,628 |   |     | $ |         5,646,878 |   |

<div align='center'>The accompanying notes are an integral part of the unaudited condensed financial statements.

F-25

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.PURSUANT TO 17 C.F.R. SECTION 200.83

MEDICUS PHARMA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)</div>

| Operating expenses:                                                        |   | Three months ended June 30